Medtronic’s Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA’s Approval for Heart Failure

 Medtronic’s Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA’s Approval for Heart Failure

Medtronic’s Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA’s Approval for Heart Failure

Shots:

  • The Attain Stability Quad MRI Surescan left heart lead with quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) & pacemakers (CRT-P) is targeted for precise lead placement and stability and will be available in the US in H1’19
  • The Attain Stability Quad lead is a quadripolar lead with a side-helix allowing the physicians to fixate the leads in sizes of veins
  • CRT is an implantable device sending leads for the stimulation of heart muscles leading to an improvement in heart pumping efficiency to treat heart failure. Additionally, Medtronic’s portfolio has therapies & diagnostic tools for HF including MR-conditional CRT-Ds and CRT-Ps

Click here to read full press release/ article | Ref: GlobeNewswire | Image: Gizmodo

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post